422 related articles for article (PubMed ID: 22956069)
1. When is a lymph node dissection a lymph node dissection? The number of lymph nodes resected in sentinel and axillary lymph node dissections.
Olaya W; Wong J; Wong J; Morgan J; Kazanjian K; Lum S
Ann Surg Oncol; 2013 Feb; 20(2):627-32. PubMed ID: 22956069
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node.
Khakpour N; Hunt KK; Kuerer HM; Yi M; Meric-Bernstam F; Ross MI; Lucci A
Am J Surg; 2005 Oct; 190(4):598-601. PubMed ID: 16164930
[TBL] [Abstract][Full Text] [Related]
3. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
4. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.
Lucci A; McCall LM; Beitsch PD; Whitworth PW; Reintgen DS; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Giuliano AE;
J Clin Oncol; 2007 Aug; 25(24):3657-63. PubMed ID: 17485711
[TBL] [Abstract][Full Text] [Related]
5. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
[TBL] [Abstract][Full Text] [Related]
6. Axillary disease recurrence after sentinel lymph node dissection for breast carcinoma.
Swenson KK; Mahipal A; Nissen MJ; Tuttle TM; Heaton K; Lally RM; Spomer A; Lee MW
Cancer; 2005 Nov; 104(9):1834-9. PubMed ID: 16161037
[TBL] [Abstract][Full Text] [Related]
7. The evolution of the sentinel node procedure in the treatment of breast cancer.
Tvedskov TF
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
[TBL] [Abstract][Full Text] [Related]
8. Improved axillary staging of breast cancer with sentinel lymphadenectomy.
Giuliano AE; Dale PS; Turner RR; Morton DL; Evans SW; Krasne DL
Ann Surg; 1995 Sep; 222(3):394-9; discussion 399-401. PubMed ID: 7677468
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting axillary lymph node retrieval and assessment in breast cancer patients.
Cil T; Hauspy J; Kahn H; Gardner S; Melnick W; Flynn C; Holloway CM
Ann Surg Oncol; 2008 Dec; 15(12):3361-8. PubMed ID: 18830666
[TBL] [Abstract][Full Text] [Related]
10. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
Helyer LK; Varnic M; Le LW; Leong W; McCready D
Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
[TBL] [Abstract][Full Text] [Related]
11. Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment?
Port ER; Patil S; Stempel M; Morrow M; Cody HS
Cancer; 2010 Apr; 116(8):1987-91. PubMed ID: 20151427
[TBL] [Abstract][Full Text] [Related]
12. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer.
Giuliano AE; Haigh PI; Brennan MB; Hansen NM; Kelley MC; Ye W; Glass EC; Turner RR
J Clin Oncol; 2000 Jul; 18(13):2553-9. PubMed ID: 10893286
[TBL] [Abstract][Full Text] [Related]
13. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.
Giuliano AE; Ballman K; McCall L; Beitsch P; Whitworth PW; Blumencranz P; Leitch AM; Saha S; Morrow M; Hunt KK
Ann Surg; 2016 Sep; 264(3):413-20. PubMed ID: 27513155
[TBL] [Abstract][Full Text] [Related]
14. Sentinel Lymph Node Dissection in Locally Recurrent Breast Cancer.
Uth CC; Christensen MH; Oldenbourg MH; Kjær C; Garne JP; Teilum D; Kroman N; Tvedskov TF
Ann Surg Oncol; 2015 Aug; 22(8):2526-31. PubMed ID: 25564177
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph-node biopsy compared to axillary lymph-node dissection for axillary staging in breast cancer patients.
Schrenk P; Shamiyeh A; Wayand W
Eur J Surg Oncol; 2001 Jun; 27(4):378-82. PubMed ID: 11417984
[TBL] [Abstract][Full Text] [Related]
16. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
17. Quantifying the number of lymph nodes identified in one-stage versus two-stage axillary dissection in breast cancer.
Damgaard OE; Jensen MB; Kroman N; Tvedskov TF
Breast; 2013 Feb; 22(1):44-6. PubMed ID: 22494665
[TBL] [Abstract][Full Text] [Related]
18. Extent of regional lymph node surgery and impact on outcomes in patients with early-stage breast cancer and limited axillary disease undergoing mastectomy.
Picado O; Khazeni K; Allen C; Yakoub D; Avisar E; Kesmodel SB
Breast Cancer Res Treat; 2018 Sep; 171(2):461-469. PubMed ID: 29869773
[TBL] [Abstract][Full Text] [Related]
19. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.
Giuliano AE; Hunt KK; Ballman KV; Beitsch PD; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; McCall LM; Morrow M
JAMA; 2011 Feb; 305(6):569-75. PubMed ID: 21304082
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]